Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 246

1.

Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer.

Zaman MS, Thamminana S, Shahryari V, Chiyomaru T, Deng G, Saini S, Majid S, Fukuhara S, Chang I, Arora S, Hirata H, Ueno K, Singh K, Tanaka Y, Dahiya R.

PLoS One. 2012;7(11):e50203. doi: 10.1371/journal.pone.0050203. Epub 2012 Nov 26.

2.

miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Chen X, Ruan A, Wang X, Han W, Wang R, Lou N, Ruan H, Qiu B, Yang H, Zhang X.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1295-304. doi: 10.1007/s00432-014-1690-7. Epub 2014 May 7.

PMID:
24802708
3.

MicroRNA-200a-3p suppresses tumor proliferation and induces apoptosis by targeting SPAG9 in renal cell carcinoma.

Wang X, Jiang F, Song H, Li X, Xian J, Gu X.

Biochem Biophys Res Commun. 2016 Feb 12;470(3):620-626. doi: 10.1016/j.bbrc.2016.01.095. Epub 2016 Jan 23.

PMID:
26797273
4.

miR-144-3p serves as a tumor suppressor for renal cell carcinoma and inhibits its invasion and metastasis by targeting MAP3K8.

Liu F, Chen N, Xiao R, Wang W, Pan Z.

Biochem Biophys Res Commun. 2016 Nov 4;480(1):87-93. doi: 10.1016/j.bbrc.2016.10.004. Epub 2016 Oct 4.

PMID:
27717821
5.

Downregulation of miR-193a-3p inhibits cell growth and migration in renal cell carcinoma by targeting PTEN.

Liu L, Li Y, Liu S, Duan Q, Chen L, Wu T, Qian H, Yang S, Xin D.

Tumour Biol. 2017 Jun;39(6):1010428317711951. doi: 10.1177/1010428317711951.

PMID:
28639901
6.

microRNA-21 governs TORC1 activation in renal cancer cell proliferation and invasion.

Dey N, Das F, Ghosh-Choudhury N, Mandal CC, Parekh DJ, Block K, Kasinath BS, Abboud HE, Choudhury GG.

PLoS One. 2012;7(6):e37366. doi: 10.1371/journal.pone.0037366. Epub 2012 Jun 4.

7.

MicroRNA-509-3p inhibits cancer cell proliferation and migration by targeting the mitogen-activated protein kinase kinase kinase 8 oncogene in renal cell carcinoma.

Su Z, Chen D, Zhang E, Li Y, Yu Z, Shi M, Jiang Z, Ni L, Yang S, Gui Y, Ye J, Lai Y.

Mol Med Rep. 2015 Jul;12(1):1535-43. doi: 10.3892/mmr.2015.3498. Epub 2015 Mar 17.

PMID:
25815776
8.

MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.

Yamasaki T, Seki N, Yoshino H, Itesako T, Hidaka H, Yamada Y, Tatarano S, Yonezawa T, Kinoshita T, Nakagawa M, Enokida H.

J Urol. 2013 Sep;190(3):1059-68. doi: 10.1016/j.juro.2013.02.089. Epub 2013 Feb 27.

PMID:
23454155
9.

Tumor suppressive microRNA-1285 regulates novel molecular targets: aberrant expression and functional significance in renal cell carcinoma.

Hidaka H, Seki N, Yoshino H, Yamasaki T, Yamada Y, Nohata N, Fuse M, Nakagawa M, Enokida H.

Oncotarget. 2012 Jan;3(1):44-57.

10.

Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.

Hirata H, Ueno K, Nakajima K, Tabatabai ZL, Hinoda Y, Ishii N, Dahiya R.

Br J Cancer. 2013 May 28;108(10):2070-8. doi: 10.1038/bjc.2013.173. Epub 2013 Apr 16.

11.

Genistein up-regulates tumor suppressor microRNA-574-3p in prostate cancer.

Chiyomaru T, Yamamura S, Fukuhara S, Hidaka H, Majid S, Saini S, Arora S, Deng G, Shahryari V, Chang I, Tanaka Y, Tabatabai ZL, Enokida H, Seki N, Nakagawa M, Dahiya R.

PLoS One. 2013;8(3):e58929. doi: 10.1371/journal.pone.0058929. Epub 2013 Mar 12.

12.

Cooperative Effect of miR-141-3p and miR-145-5p in the Regulation of Targets in Clear Cell Renal Cell Carcinoma.

Liep J, Kilic E, Meyer HA, Busch J, Jung K, Rabien A.

PLoS One. 2016 Jun 23;11(6):e0157801. doi: 10.1371/journal.pone.0157801. eCollection 2016.

13.

Expression and functional role of miR-29b in renal cell carcinoma.

Xu Y, Zhu J, Lei Z, Wan L, Zhu X, Ye F, Tong Y.

Int J Clin Exp Pathol. 2015 Nov 1;8(11):14161-70. eCollection 2015.

14.

Up-regulation of microRNA-21 correlates with lower kidney cancer survival.

Zaman MS, Shahryari V, Deng G, Thamminana S, Saini S, Majid S, Chang I, Hirata H, Ueno K, Yamamura S, Singh K, Tanaka Y, Tabatabai ZL, Dahiya R.

PLoS One. 2012;7(2):e31060. doi: 10.1371/journal.pone.0031060. Epub 2012 Feb 8.

15.

miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.

Xu M, Gu M, Zhang K, Zhou J, Wang Z, Da J.

Diagn Pathol. 2015 Apr 9;10:24. doi: 10.1186/s13000-015-0255-7.

16.

Identification of miR-508-3p and miR-509-3p that are associated with cell invasion and migration and involved in the apoptosis of renal cell carcinoma.

Zhai Q, Zhou L, Zhao C, Wan J, Yu Z, Guo X, Qin J, Chen J, Lu R.

Biochem Biophys Res Commun. 2012 Mar 23;419(4):621-6. doi: 10.1016/j.bbrc.2012.02.060. Epub 2012 Feb 17.

PMID:
22369946
17.

Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.

Au Yeung CL, Tsang TY, Yau PL, Kwok TT.

Oncogene. 2011 May 26;30(21):2401-10. doi: 10.1038/onc.2010.613. Epub 2011 Jan 17.

PMID:
21242962
18.

Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells.

Jiang L, Huang Q, Zhang S, Zhang Q, Chang J, Qiu X, Wang E.

BMC Cancer. 2010 Jun 22;10:318. doi: 10.1186/1471-2407-10-318.

20.

miRNA-221 promotes proliferation, migration and invasion by targeting TIMP2 in renal cell carcinoma.

Lu GJ, Dong YQ, Zhang QM, Di WY, Jiao LY, Gao QZ, Zhang CG.

Int J Clin Exp Pathol. 2015 May 1;8(5):5224-9. eCollection 2015.

Supplemental Content

Support Center